# Long Hill Capital

> Long Hill Capital is a VC fund in Shanghai backing Medical and Health Care. See 44 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 44
- Last investment: Apr 2024
- Lead investor: 39%
- Last fund: Apr 2021
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/long-hill-capital
- X (Twitter): https://twitter.com/LongHillCap
- Website: http://www.lhcap.cn/
- Facebook: https://www.facebook.com/lhcap

Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.

## Contacts

5 contacts available for Long Hill Capital. Shizune tracks 3 team members at Long Hill Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/long-hill-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.8M–$20M |
| Series B | $14M–$100M |
| Series C | $15M–$60M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 12 | 27% |
| Health Care | 12 | 27% |
| Training | 3 | 7% |
| Biotechnology | 3 | 7% |
| Medical Device | 3 | 7% |

32 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 13 | 30% |
| Series B | 10 | 23% |
| Series C | 5 | 11% |
| Seed | 3 | 7% |
| Angel | 2 | 5% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 26 | 59% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hangcheng Sun | Investment Director | 0 | https://shizune.co/investors/profile/hangcheng-sun |
| Song Mei | Vice President | 0 | https://shizune.co/investors/profile/song-mei |
| Xiaodong Jiang | Managing Partner | 19 | https://shizune.co/investors/profile/xiaodong-jiang |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oushisheng Technology | Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world. |  | Series B | Apr 03, 2024 |  |
| Filan Air | Filan Air develops technology for improving air quality, such as air treatment for medical laboratories. | $13.7M | Series B | Oct 17, 2023 |  |
| Aibo Medical Robot | Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team. | $14.1M | Series A | Jun 01, 2023 |  |
| Oushisheng Technology | Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world. | $7.2M | Venture - Series Unknown | Apr 25, 2023 |  |
| Fuxin Technology Innovation | Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software. | $7.3M | Angel | Mar 14, 2023 |  |
| Wangli Technology | Wangli Technology is a digital therapy technology platform for mental illness focusing on exploring the field of human brain and spirit. | $14.4M | Venture - Series Unknown | Dec 05, 2022 |  |
| Qingyun Technology | Qingyun Technology is an artificial intelligence digital marketing platform company focusing on the pharmaceutical industry. |  | Series C | Oct 08, 2022 |  |
| Shengnuo Medical | Sono Medical is a biomedical technology company that focuses on R&D, design, production and sales of edical equipment in the field of cardiovascular diseases. |  | Series A | Sep 28, 2022 |  |
| BestCovered | BestCovered is a provider of systematic multi-dimensional activation courses to help maintain a flexible mind. | $14.3M | Series A | Sep 16, 2022 |  |
| Lab Direct | Lab Direct is a developer of an online supply chain and procurement service platform that helps laboratories and research institutions to directly connect with suppliers and potential partners to get access to necessary equipment and supplies. The company was founded in 2014 and is headquartered in Shanghai, China. | $10M | Series A | Aug 26, 2022 |  |

10 of 44 investments shown.

## Co-investors
- [Cenova](https://shizune.co/investors/profile/cenova-ventures) — VC Fund, 5 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 4 deals together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 4 deals together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 3 deals together
- [Eastern Bell Capital](https://shizune.co/investors/profile/eastern-bell-venture-capital) — VC Fund, 3 deals together
- [Eight Roads Ventures](https://shizune.co/investors/profile/eight-roads-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Medical Investors in Asia](https://shizune.co/investors/medical-investors-asia)
- [Medical VC Funds in Asia](https://shizune.co/investors/medical-vc-funds-asia)
- [Medical Investors in China](https://shizune.co/investors/medical-investors-china)
- [Medical VC Funds in China](https://shizune.co/investors/medical-vc-funds-china)
- [Medical Device VC Funds in China](https://shizune.co/investors/medical-device-vc-funds-china)

## FAQ

### What does Long Hill Capital invest in?

Long Hill Capital invests primarily in Medical, Health Care and Training startups, most often at Series A and Series B stage. Most of the 44 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Long Hill Capital's check size?

Long Hill Capital typically joins rounds of $1.8M–$20M at Series A, $14M–$100M at Series B and $15M–$60M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Long Hill Capital participates in.

### How do I contact Long Hill Capital?

Public channels for Long Hill Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Long Hill Capital?

The team at Long Hill Capital includes Hangcheng Sun (Investment Director), Song Mei (Vice President) and Xiaodong Jiang (Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co